Analyzing Clorox’s Performance in the Fourth Fiscal Quarter
Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY.
Procter & Gamble Beats Third-Quarter Estimates
Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.
Colgate-Palmolive’s Developed Markets Remained a Drag in 1Q17
Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.
Factors That Could Impact Kimberly-Clark’s Earnings in 2018
Kimberly-Clark (KMB) has managed to increase its EPS (earnings per share) despite volume deleveraging.
Why Kimberly-Clark Stock Is Down 12.5% Year-to-Date
Similar to its peers, Kimberly-Clark stock is also trading in the red and is down about 12.5% on a YTD (year-to-date) basis as of March 26, 2018.
Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?
Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%.
Government Sector Influenced Personal Income and Expenses Rose
According to the BEA, personal income rose 0.30% to $52.5 billion in August 2015. This was below the consensus estimate of 0.40%.
Kimberly-Clark Stock: Headwinds Could Stall the Uptrend
Analysts expect Kimberly-Clark’s sales and margins to remain weak in the near term. Kimberly-Clark’s top line is projected to decline.
Clorox’s Fiscal 2Q16 Revenue Is Estimated to Be $1.3 Billion
For fiscal 2Q16, Wall Street analysts’ consensus revenue estimate for Clorox is ~$1.3 billion, a 3.4% rise from the same quarter last year.
What Drove Colgate-Palmolive’s Margins Growth in 1Q17?
Colgate-Palmolive (CL) witnessed improved margins in 1Q17 despite soft sales thanks to its “Funding the Growth” initiative aimed at reducing costs and driving efficiency.
How Procter & Gamble’s Segments Performed in 3Q18
Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity.
Why Analysts Expect Clorox’s Earnings to Fall in Fiscal 2Q18
Analysts expect Clorox to report adjusted earnings of $1.23 per share, a YoY (year-over-year) decline of 1.6%.
Why SunTrust Upgraded Colgate-Palmolive Stock
On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.
Will Procter & Gamble’s Sales Improve in Fiscal 2017?
After generating lower sales for 11 consecutive quarters, Procter & Gamble (PG) managed to report flat sales growth in fiscal 1Q17.
Analysts Remain Neutral on Clorox Stock before 4Q17 Results
Analysts covering Clorox (CLX) have rated the stock a 2.9 on a scale of one (strong buy) to five (strong sell) and maintain a neutral outlook.
Will Cost Pressures Hurt KMB’s Q2 2018 EPS Growth Rate?
Analysts expect Kimberly-Clark (KMB) to report adjusted EPS of $1.57 in the second quarter.
Procter & Gamble’s Margins Could Remain Muted
Procter & Gamble’s management remains upbeat and expects productivity savings to drive its margins higher in coming quarters.
What’s behind Clorox’s Fiscal 3Q17 Earnings Beat?
The Clorox Company (CLX) reported its fiscal 3Q17 results on May 3, 2017. Its EPS (earnings per share) of $1.31 exceeded analysts’ consensus estimate of $1.30.
How Do Analysts Rate Clorox and Its Peers?
Of the 17 analysts covering Clorox Company (CLX), two analysts have rated the stock as a “buy” as of November 2.
How PG’s Valuation Compares to Peers
As of April 18, Procter & Gamble (PG) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.8x.
Henkel Acquired Procter & Gamble’s Haircare Brands
Procter & Gamble (PG) has a market cap of $224.1 billion. PG rose by 0.35% to close at $82.84 per share on March 3, 2016.
How PG’s Valuation Looks Now
As of March 8, PG was trading at a 12-month forward PE ratio of 22.7x. The company is now trading at a higher valuation multiple than the S&P 500 Index.
Kimberly-Clark Appoints Scott Usitalo as Chief Marketing Officer
Kimberly-Clark (KMB) has a market cap of $47.6 billion. It rose by 1.7% to close at $132.41 per share on June 14, 2016.
Procter & Gamble: Can Focus on 10 Product Categories Help 3Q16?
Procter & Gamble (PG) is set to release its fiscal 3Q16 earnings before the Markets open on April 26, 2016. In fiscal 2Q16, P&G missed revenue estimates for the fifth consecutive quarter.
How Is Clorox Improving Product Distribution?
For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.
Mega Brands Set to Dominate in P&G’s New Product Portfolio
P&G plans to focus on superior brands in the 10 product categories in its portfolio. It expects one-third of them to surpass $1 billion in annual sales.
Why Did Clorox China Recall Some of Its Products?
The Clorox Company (CLX) has a market cap of $15.0 billion. It fell 0.67% and closed at $115.48 per share on November 23, 2016.
Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?
Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22.
Here’s What’s behind PG’s Fiscal 3Q17 Bottom Line Beat
Procter & Gamble reported its fiscal 3Q17 results on April 26, 2017. Its adjusted EPS of $0.96 exceeded Wall Street’s consensus estimate of $0.94 and jumped 11.6% YoY (year-over-year), thanks to lower taxes.
How Does Colgate-Palmolive’s Valuation Compare?
12-month forward price-to-earnings multiple As of January 17, Colgate-Palmolive (CL) was trading at a 12-month forward PE (price-to-earnings) multiple of 22.2x. The company is currently trading at a higher valuation multiple than the S&P 500, which has a forward PE of 17.6x, and the S&P 500 Consumer Staples, which has a forward PE of 20.3x. […]
Procter & Gamble Kicked off the Campaign for Its Pantene Brand
Procter & Gamble (PG) fell 1.8% to close at $83.58 per share during the second week of November 2016.
Weak Currencies, but Consumer Packaged Goods Margins Improved
The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.
What Could Stall the Recovery in Kimberly-Clark Stock?
Kimberly-Clark (KMB) stock has recovered nearly 6% in the last two trading days.
What Dragged Colgate-Palmolive’s Sales Down in Q4?
Colgate-Palmolive (CL) posted net sales of $3.8 billion, a decline of about 2% on a YoY (year-over-year) basis, as unfavorable currency rates hurt the top line by 5%.
Millennium Management adds new position in St. Jude Medical
St. Jude Medical, Inc. is a global medical device company founded in 1976. It has more than 20 principal operations and manufacturing facilities worldwide.
What’s behind Procter & Gamble’s Improving Dividend Trend?
Procter & Gamble recently announced a 4% hike in its quarterly dividend to $0.72 per share.
Barclays Upgraded Clorox to ‘Equal-Weight’
On January 9, 2017, Barclays upgraded Clorox’s rating to “equal-weight” from “underweight.” It set the stock’s price target at $111.0 from $115.0 per share.
Can Procter & Gamble’s Stock Price Gain Momentum?
Procter & Gamble’s stock has consistently fallen since the beginning of 2015. However, the stock was able to sustain some gains until September.
Why Colgate-Palmolive’s Margins May Improve in 2Q17
Colgate-Palmolive (CL) has resorted to cost-cutting and productivity savings measures to drive margins growth.
Why Clorox’s Top Line Could Continue to Impress in 2018
Clorox (CLX) registered healthy volumes growth in the United States (SPY) in 2017, which differentiates it from its peers.
Why Kimberly-Clark’s Gross Margins Fell Significantly in 1Q18
Kimberly-Clark’s adjusted operating margin fell 140 basis points to 17.4%, reflecting a lower gross margin.
Clorox Disappoints on Outlook
Clorox (CLX) continued its strong top-line and bottom-line performances in fiscal 1Q18.
Why Kimberly-Clark’s EPS Could Decline in Q1 2019
Analysts expect Kimberly-Clark to post adjusted earnings of $1.54 per share in the first quarter of 2019, which implies a YoY decline of 9.9%.
Could Kimberly-Clark’s Sales Recover in 2018?
Continued challenges in developed markets, especially North America, have taken a toll on Kimberly-Clark’s (KMB) top-line performance.
What Could Hurt Kimberly-Clark Stock?
Among 19 analysts covering Kimberly-Clark stock, 13 recommend a “hold,” four recommend a “sell,” and two recommend a “buy” rating.
How Colgate Is Maintaining Margins in the Face of Headwinds
Colgate’s worldwide gross profit margin fell to 58.5% in 2014 from 58.6% in 2013.
What’s Behind Clorox’s Industry-Leading Sales Growth?
The Clorox Company (CLX) has managed to generate industry-leading sales despite challenges.
Procter & Gamble Stock: Analysts’ Ratings Trend
Of the 23 analysts covering Procter & Gamble stock, 74.0% recommend a “hold,” 22.0% recommend a “buy,” and 4.0% recommend a “sell.”
Here’s What Drove Kimberly-Clark’s Margins in 1Q17
Kimberly-Clark (KMB) generated about $110.0 million in cost savings in 1Q17 and remains on track to save about $400.0 million in 2017.
Will the Rally in Clorox Stock Continue?
The COVID-19 pandemic boosted Clorox’s (NYSE:CLX) sales. People started paying more attention to cleaning and sanitizing.
Is Clorox a ‘Buy’ after Its Stellar Q3 Results?
Clorox (NYSE:CLX) raised its outlook for 2020 after the company generated strong sales in the third quarter of fiscal 2020.
Why Investors Expect Clorox to Deliver Strong Q1 Results
Increased hygiene requirements amid COVID-19 caused a major rise in demand for Clorox’s tissues, disinfectants, and other cleaning products.
Procter & Gamble Delivers Mixed Q3 Results amid COVID-19
Today, Procter & Gamble (NYSE:PG) announced better-than-expected earnings for the third quarter of fiscal 2020. The fiscal third quarter ended on March 31.
Jefferies Upgraded Procter & Gamble and Kimberly Clark
Jefferies is bullish about consumer staples giants Procter & Gamble (NYSE:PG) and Kimberly Clark (NYSE:KMB). The firm upgraded both of the stocks.
Is Procter & Gamble a Good Bet for Investors?
The defensive nature of Procter & Gamble stock and its strong dividends make it a good buy in a challenging market environment.
Clorox Gets Rating Upgrade, Coronavirus Triggers Demand
Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.
Why 2019 Wasn’t As Good As 2018 for Church & Dwight Stock
Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.
Procter & Gamble Stock: What’s Fueling the Growth?
Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.
Why Church & Dwight Stock Is Underperforming Its Peers
Church & Dwight stock is lagging behind its peers by a wide margin so far this year. High valuation and moderating growth are to blame.
Why Colgate-Palmolive’s Q3 Earnings Failed to Impress
Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.
Why Church & Dwight Fell despite Its Q3 EPS Beat
Church & Dwight (CHD) stock was trading about 4% lower in morning trading after its third-quarter sales miss irked investors.
Church & Dwight Stock: Q3 Earnings Might Spur Growth
Most of the analysts maintained a neutral outlook on Church & Dwight stock before the third-quarter earnings announcement.
Why Procter & Gamble Stock Might Not Cool Off
So far, Procter & Gamble stock has outperformed the broader markets by a wide margin. Procter & Gamble stock has risen 33.8% on a YTD basis.
Procter & Gamble Crushed Estimates, Stock Rose
Procter & Gamble (PG) posted impressive results for the first quarter of fiscal 2020 today. The company’s revenues and EPS beat analysts’ estimates.
Procter Gamble: Q1 Earnings Could Drive Its Stock
Procter & Gamble (PG) is scheduled to announce its earnings for the first quarter of fiscal 2020 before the markets open on Tuesday.
Procter & Gamble: Fiscal 2020 Could Start Strong
Procter & Gamble was up 27.9% YTD on October 16, outperforming the broader markets by a wide margin. PG plans to announce its Q1 earnings on October 22.
P&G Beats Estimates and Posts Best Organic Sales in Decade
P&G’s sales and EPS handily exceeded analysts’ expectations thanks to the robust organic sales growth.
Kimberly-Clark and Clorox: Barclays Is Bullish and Bearish
On September 23, Barclays analyst Lauren Lieberman upgraded Kimberly-Clark (KMB) stock and downgraded the Clorox Company (CLX) stock.
Procter & Gamble Stock: Valuation Limits Upside
Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.
Church & Dwight Stock: Valuation Overshadows Growth
Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.
Will Procter & Gamble Stock Sustain the Rally?
While we expect sustained momentum in the base business to support Procter & Gamble stock, its valuation suggests otherwise.
CL and KMB: Why Their Upside May Be Capped
CL and KMB stocks have outperformed the broader markets this year. However, any further upside in the stocks seems capped.
Procter & Gamble Stock: What’s behind Its Solid Return?
Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.
Why These Dividend-Paying Consumer Stocks Look Attractive
As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.
Clorox Posts Mixed Q4 Results, Weakness to Persist
On Thursday, Clorox posted mixed fourth-quarter results. Clorox reported net revenues of $1.63 billion, which fell short of analysts’ estimate.
Colgate-Palmolive’s Q2 EPS Met Estimates
Colgate-Palmolive (CL) announced its second-quarter results on July 26.
Procter & Gamble Will Likely Beat Q4 Estimates
Procter & Gamble (PG) is scheduled to announce to its fourth-quarter earnings on July 30. We expect the company to beat analysts’ estimates.
Kimberly-Clark Beats Estimates, Raises Guidance
On July 23, Kimberly-Clark (KMB) posted stronger-than-expected second-quarter earnings results. It surpassed analysts’ expectations on both the sales and EPS fronts.
Will Kimberly-Clark’s Q2 Boost Its Share Price?
Kimberly-Clark (KMB) will likely report its second-quarter results before the markets open on July 23. We expect the company’s sales and earnings to stay muted.
Church & Dwight Continues to Outperform with Its Earnings Growth
Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.
Why Kimberly-Clark Stock May Stop Rising
Kimberly-Clark (KMB) stock has risen 20.5% this year, boosted by the company’s better-than-expected sales and earnings during its last reported quarter. However, its stock could stop climbing. Here’s why.
Why Clorox Stock Is Underperforming Peers
Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.
Q1 Beat and Improved Outlook Could Boost Church & Dwight Stock
Church & Dwight (CHD) has impressed with its better-than-expected first-quarter results and margin expansion.
Currency and Competition Hurt Clorox’s Q3 Sales
Clorox (CLX) posted net sales of $1.55 billion, which fell short of Wall Street’s estimate of $1.57 billion.
Clorox Stock Drops 7.2% on Weak Quarterly Results
Clorox (CLX) stock fell 7.2% on May 1 following the company’s weaker-than-expected third-quarter results.
What’s on the Horizon for Colgate-Palmolive Stock?
Most of the analysts maintained a neutral stance on Colgate-Palmolive stock. Persistent challenges will likely limit the upside.
Colgate-Palmolive Beats Estimates on Higher Pricing
Colgate-Palmolive (CL) posted better-than-expected first-quarter earnings results on April 26.
Procter & Gamble Posted Strong Sales in Q3
Procter & Gamble (PG) posted better-than-expected third-quarter sales. Procter & Gamble’s net sales of $16.5 billion beat analysts’ estimate.
Procter & Gamble Stock Fell despite Strong Q3 Results
Procter & Gamble posted impressive third-quarter results on April 23. Organic sales rose 5% due to stellar growth in the United States and China.
What Drove Kimberly-Clark’s Q1 Earnings?
Kimberly-Clark (KMB) posted better-than-expected earnings in the first quarter of 2019.
What’s behind Kimberly-Clark’s Strong Organic Sales?
Kimberly-Clark (KMB) posted better-than-expected first-quarter sales thanks to the strong growth in its base business.
Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results
Kimberly-Clark (KMB) stock rose 5.4% on April 22 after the company released stronger-than-expected first-quarter results.
Persisting Challenges Could Hurt Colgate-Palmolive in Q1
Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26.
What Analysts Suggest for PG Stock ahead of Its Q3 Results
The majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock.
What to Expect from Procter & Gamble’s Q3 2019 Results
Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.
Is Kimberly-Clark Stock Heading for a Decline?
Kimberly-Clark (KMB) stock has increased 8.1% so far this year and trades at a forward PE multiple of 18.7x
Why Kimberly-Clark’s Sales Could Continue to Decline in Q1
Kimberly-Clark (KMB) has exceeded analysts’ sales estimate in the past two consecutive quarters.
Why Analysts Have a Bleak Outlook for Kimberly-Clark’s Q1
Kimberly-Clark (KMB) is expected to announce its first-quarter results before the markets open on Monday, April 22.
Where Clorox Stock Could Be Heading
Clorox stock is trading at a forward PE multiple of 24.1x, which looks unattractive given its projected growth rate of 6.3% for fiscal 2020.
Why JPMorgan Chase Has Downgraded Clorox Stock
The Clorox Company (CLX) stock fell ~1% on April 8 after JPMorgan Chase downgraded it to an “underweight” from a “neutral.”